Clinical Trial Update: Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating lithium and valproate for high-risk bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Lithium (Lithium carbonate)
• Valproate (valproate)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Bipolar Disorder | Phase 1 | Status: COMPLETED